Fabian Zanella’s scientific expertise is focused on cell-based assay development, and applications of human induced pluripotent stem cells (hiPSCs)-derived cells in drug screening and disease modelling. Fabian joined the core founding team StemoniX as their first employee and has been directly involved in steering the R&D activities at StemoniX in the design, validation and implementation of high throughput physiologically relevant screening platforms involving hiPSC-derived cardiomyocytes and hiPSC-derived cells from the neuronal lineage.